You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on CypComp Database.
Record Information
Version1.0
Creation Date2019-07-14 16:35:51 UTC
Last Updated2019-10-01 21:41:05 UTC
CypComp IDCC01937
Compound Information
NameDY-9760E
Structure ImageKswpgvnflobebo uhfffaoysa n
InChIKeyKSWPGVNFLOBEBO-UHFFFAOYSA-N
PubChem ID9870401
CypCompound Information
SetCypBoM Training Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • <10,7;Cleavage;R1>
  • <10,H;Oxidation;R1>
  • <27,H;Hydroxylation;R2>
  • <13,H;Oxidation;R3>
  • <12,13;Reduction;R3>
  • Not Available
  • Not Available
  • <10,7;Cleavage;R1>
  • <10,H;Oxidation;R1>
  • <27,H;Hydroxylation;R2>
  • <35,32;Cleavage;R3>
  • <35,H;Oxidation;R3>
  • <13,H;Oxidation;R4>
  • <12,13;Reduction;R4>
  • <10,7;Cleavage;R1>
  • <10,H;Oxidation;R1>
  • <35,32;Cleavage;R2>
  • <35,H;Oxidation;R2>
  • <27,H;Hydroxylation;R3>
  • <13,H;Oxidation;R4>
  • <12,13;Reduction;R4>
  • <10,7;Cleavage;R1>
  • <10,H;Oxidation;R1>
  • <27,H;Hydroxylation;R2>
  • <35,32;Cleavage;R3>
  • <35,H;Oxidation;R3>
  • <34,33;Cleavage;R4>
  • <34,H;Oxidation;R4>
  • <13,H;Oxidation;R5>
  • <12,13;Reduction;R5>
  • <10,7;Cleavage;R1>
  • <10,H;Oxidation;R1>
  • <27,H;Hydroxylation;R2>
  • <35,32;Cleavage;R3>
  • <35,H;Oxidation;R3>
  • <34,33;Cleavage;R4>
  • <34,H;Oxidation;R4>
  • <13,H;Oxidation;R5>
  • <12,13;Reduction;R5>
  • Not Available
  • <10,7;Cleavage;R1>
  • <10,H;Oxidation;R1>
  • <34,33;Cleavage;R2>
  • <34,H;Oxidation;R2>
  • <13,H;Oxidation;R3>
  • <12,13;Reduction;R3>
  • <35,32;Cleavage;R4>
  • <35,H;Oxidation;R4>
  • <27,H;Hydroxylation;R5>
  • <15,H;Hydroxylation;R6>
References
  1. Tachibana S, Fujimaki Y, Yokoyama H, Okazaki O, Sudo K: In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidaz olylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions. Drug Metab Dispos. 2005 Nov;33(11):1628-36. doi: 10.1124/dmd.105.004903. Epub 2005 Jul 27. [PubMed:16049129 ]
Download FileCC01937.sdf